Solicitation - Notice of Intent to SS.pdf

PDF 69 KB Posted

Attached to
Purchase of Thermo Fisher reagents and supplies for immunology studies
Solicitation number
FDA-CDER-25-130466
Issued by

About this file

This document is a Notice of Intent to Sole Source issued by the Food and Drug Administration (FDA) on September 10, 2025, for the purchase of Thermo Fisher reagents and supplies for immunology studies under contract number FDA-CDER-25-130466. The FDA intends to award a Firm Fixed Price contract to Fisher Scientific Company LLC, located in Hanover Park, Illinois, using FAR Part 6.302-1(a)(2)(ii) which allows for a sole source procurement when only one responsible source can satisfy agency requirements.

The notice invites potential vendors to submit a written capability statement by September 15, 2025, at 12:00 PM EST to rodney.aytch@fda.hhs.gov if they believe they can meet the minimum requirements outlined in an attached Statement of Work. While the FDA anticipates awarding the contract to Fisher Scientific Company LLC within five days of the notice, the agency reserves the right to compete the contract based on any submitted capability statements. The final determination to proceed with the sole source award or pursue a competitive procurement remains solely at the government's discretion.

View the file

Other files

File Type Posted
Requirements Document.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

September 10, 2025 Notice of Intent to Sole Source

Purchase of Thermo Fisher reagents and supplies for immunology studies

FDA-CDER-25-130466

The Food and Drug Administration (FDA) intends to award a Sole Source Firm Fixed Price contract order to Fisher

Scientific Company LLC, 4500 Turnberry Dr., Hanover Park, Ill 60133-5491

In accordance with FAR Part 6.302-1 (a) (2)(ii) which states” Only one responsible source and no other supplies or services will satisfy agency requirement”.

The purpose of this notice is to inform the public that the Food and Drug Administration (FDA) anticipates issuing a Firm Fixed Price contract.

MINIMUM REQUIREMENTS:

See Attached Statement of Work

This notice is not a request for competitive proposals. However, any party that believes it can meet this requirement as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement.

Capability statements must be received by the response date and time of this notice. Submissions will be reviewed to determine if they can meet the requirement. A determination by the Government to compete this proposed contract based upon responses to this notice is solely within the discretion of the

Government.

It is anticipated that an award will be issued to Fisher Scientific Company, LLC within approximately five (5) days after the date of this notice unless the Government determines that any other organization has the capability to meet this requirement.

Response Date: September 15, 2025, by 12.00PM EST. Please email responses to Rodney D.

Aytch – rodney.aytch@fda.hhs.gov.

Rodney D. Aytch

Contract Specialist mailto:rodney.aytch@fda.hhs.gov.

File details come from the government source that posted it. Updated .